Observational studyInternal medicine journal2025
Enhancing utilisation of Hospital in the Home for intravenous diuretic therapy: a retrospective study of barriers and estimated bed substitution in general medicine inpatients with decompensated heart failure.
Observational study in Internal medicine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmbulatory treatment of decompensated heart failure (HF) with intravenous (IV) furosemide through Hospital in the Home (HITH) is safe, effective and reduces costs.
aimsWe hypothesised that this service was underutilised by general medicine and aimed to examine potential barriers and bed-day utilisation implications.
methodsIn this multi-site, retrospective observational study, we identified general medicine inpatients admitted with heart failure (HF) between November 2021 and October 2022. Those who required intravenous (IV) furosemide for >24 h were selected and included if clinically stable. Patients were grouped by 'no barriers', 'relative barriers' and 'absolute barriers' to Hospital in the Home (HITH). We estimated potential brick-and-mortar hospital bed-days that could be transferred to HITH.
resultsOf 1856 admissions coded as HF, 694 met our criteria. Of these, 311 (45%) were clinically stable, while only four were transferred to HITH. Of the remaining 307 patients, 27 (9%), 129 (42%) and 151 (49%) exhibited no, relative and absolute barriers to HITH respectively. Those with no or relative barriers (n = 156, 51% or 22% of those treated with IV furosemide) had two (interquartile range (IQR) 1-3) additional medical diagnoses and spent 4 (IQR 3-6) days in hospital while clinically stable. A 36% reduction in brick-and-mortar hospital bed-day utilisation by transferring care to HITH was estimated.
conclusionIn our health service, general medicine patients are rarely referred to HITH for IV diuresis for decompensated HF. Overcoming barriers relating to the ability of the model of care to support greater acute medical complexity could result in increased utilisation of HITH and deliver a significant reduction in brick-and-mortar hospital bed-day utilisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.